N
Market Data
$35.07+$4.30 (+13.97%)
NAMS · Last trade
Prev Close
$30.77
Range (30d)
$28.62 – $35.07
Recent Filings
- 8-K18.5 MBNewAmsterdam Pharma Co N.V.Mar 2, 8:00 AM ET·0001193125-26-084266
- 10-K18.4 MBNewAmsterdam Pharma Co N.V.Feb 18, 7:00 AM ET·0001193125-26-056029
- 8-K862.0 KBNewAmsterdam Pharma Co N.V.Feb 18, 7:00 AM ET·0001193125-26-056020
- 8-K269.8 KBNewAmsterdam Pharma Co N.V.Jan 9, 8:00 AM ET·0001193125-26-008300
- 10-Q9.5 MBNewAmsterdam Pharma Co N.V.Nov 5, 8:00 AM ET·0001193125-25-265796
- 8-K19.1 MBNewAmsterdam Pharma Co N.V.Nov 5, 8:00 AM ET·0001193125-25-265800
- 8-K18.6 MBNewAmsterdam Pharma Co N.V.Sep 2, 8:30 AM ET·0000950170-25-112345
- 8-K255.1 KBNewAmsterdam Pharma Co N.V.Aug 18, 8:00 AM ET·0000950170-25-109567
- 8-K209.8 KBNewAmsterdam Pharma Co N.V.Aug 15, 4:05 PM ET·0000950170-25-109387
- 8-K834.9 KBNewAmsterdam Pharma Co N.V.Aug 6, 7:00 AM ET·0000950170-25-103520
Insiders
10- Audet Juliette BerangereSee Remarks
- Bain Capital Life Sciences Fund III, L.P.10% Owner
- Bain Capital Life Sciences Fund II, L.P.10% Owner
- Bain Capital Life Sciences Investors, LLC10% Owner
- BCIP Life Sciences Associates, LP10% Owner
- BCLS Fund III Investments, LP10% Owner
- BCLS II Investco, LP10% Owner
- Davidson Michael H.Director, Chief Executive Officer
- Downing NicholasDirector
- Forbion Capital Fund IV Cooperatief U.A.10% Owner
Tickers
Addresses
business
GOOIMEER 2-35
NARRDEN, P7, 1411 DC
mailing
GOOIMEER 2-35
NARRDEN, P7, 1411 DC
Former Names
- NewAmsterdam Pharma Co B.V.2022-11-22